These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6578074)

  • 1. In vivo demonstration of inflammatory mediator release following nasal challenge with antigen.
    Naclerio RM; Meier HL; Adkinson NF; Kagey-Sobotka A; Meyers DA; Norman PS; Lichtenstein LM
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():26-32. PubMed ID: 6578074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediator release after nasal airway challenge with allergen.
    Naclerio RM; Meier HL; Kagey-Sobotka A; Adkinson NF; Meyers DA; Norman PS; Lichtenstein LM
    Am Rev Respir Dis; 1983 Oct; 128(4):597-602. PubMed ID: 6354022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal conditioning in perennial allergic rhinitis after nasal allergen challenge.
    Rozsasi A; Leiacker R; Keck T
    Clin Exp Allergy; 2004 Jul; 34(7):1099-104. PubMed ID: 15248856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of allergic rhinitis in nasal responses to sudden temperature changes.
    Graudenz GS; Landgraf RG; Jancar S; Tribess A; Fonseca SG; Faé KC; Kalil J
    J Allergy Clin Immunol; 2006 Nov; 118(5):1126-32. PubMed ID: 17088139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antigen-induced leukotriene and histamine release from nasal scrapings in allergic rhinitis.
    Kunitomo M; Otsuka H
    Rhinology; 2005 Sep; 43(3):199-204. PubMed ID: 16218513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis.
    Ciprandi G; Tosca MA; Milanese M; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):237-40. PubMed ID: 15329007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal mucosal expression of the leukotriene and prostanoid pathways in seasonal and perennial allergic rhinitis.
    Westergren VS; Wilson SJ; Penrose JF; Howarth PH; Sampson AP
    Clin Exp Allergy; 2009 Jun; 39(6):820-8. PubMed ID: 19364335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation.
    Zeng D; Prosperini G; Russo C; Spicuzza L; Cacciola RR; Di Maria GU; Polosa R
    J Allergy Clin Immunol; 2004 Aug; 114(2):316-20. PubMed ID: 15316509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tympanometric changes following nasal antigen challenge in children with allergic rhinitis.
    O'Connor RD; Ort H; Leong AB; Cook DA; Street D; Hamburger RN
    Ann Allergy; 1984 Dec; 53(6):468-71. PubMed ID: 6542329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic mechanisms underlying the clinical symptoms of allergic rhinitis.
    Wang DY; Clement P
    Am J Rhinol; 2000; 14(5):325-33. PubMed ID: 11068658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of leukotriene D4 in allergic rhinitis.
    Okuda M; Watase T; Mezawa A; Liu CM
    Ann Allergy; 1988 Jun; 60(6):537-40. PubMed ID: 3382059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic rhinitis: not purely a histamine-related disease.
    Howarth PH; Salagean M; Dokic D
    Allergy; 2000; 55 Suppl 64():7-16. PubMed ID: 11291780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms involved in onset of allergic manifestations in the nose.
    Konno A; Togawa K; Fujiwara T
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():155-66. PubMed ID: 6193990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some immunological parameters in serum and nasal secretion in subjects with vasomotor and allergic rhinitis and nasal polyps - a comparative study.
    Pulido V; García-Calderón PA
    Rhinology; 1983 Mar; 21(1):29-37. PubMed ID: 6857102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge.
    Wagenmann M; Schumacher L; Bachert C
    Allergy; 2005 Sep; 60(9):1132-8. PubMed ID: 16076297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an allergic rhinitis model in mice for the evaluation of nasal symptoms.
    Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
    Life Sci; 2007 Mar; 80(15):1388-94. PubMed ID: 17300813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
    Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
    Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
    Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
    Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P is generated in vivo following nasal challenge of allergic individuals with bradykinin.
    Baumgarten CR; O'Connor A; Dokic D; Schultz KD; Kunkel G
    Clin Exp Allergy; 1997 Nov; 27(11):1322-7. PubMed ID: 9420137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.